RELX PLC ORD GBP0.1444

Symbol: REL

This security went ex-dividend on 08/05/2025. Pay date is 19/06/2025

Streaming is not available when market closed. Some prices may be as at close of business from the previous working day.

Whilst we endeavour to price investments on a real-time streaming or 15 min delayed basis, some prices may be as at close of business from the previous working day.

Invest in this share within an ISA, JISA, SIPP or Investment Account

Overview

Core Data
Latest Dividend Information

Ex-Dividend Date 8 May 2025
Pay Date 19 Jun 2025
Total Dividends - Year to Date63
Dividend Yield (%)1.6096

Historical Data & Ratios

Avg Volume Over 10 Days2.4403
Market Cap (M)73416.2400
Price/Earnings (PE)37.7581
Earnings Per Share103.66
Revenue Per Share5.0269
Return on Equity %55.7268

1 Month Performance Chart

One Month Chart

Broker View
Data shown is based on the past 75 days of broker views.

ActionBrokers

Strong Buy4

Buy8

Neutral4

Sell0

Strong Sell0

Brokers 4 8 4 0 0
Consensus

ConsensusBuy

Not advice based on your circumstances. Does not constitute a recommendation to buy or sell this or any other security. Selected data supplied by Digital Look® Read more.

Cost and Charges Information

This calculator provides you with costs and charges information regarding our charges and, where relevant, the costs within this investment product

Account Type

  • Investment Account
  • Stocks & Shares ISA
  • SIPP

Annual charges

These are the annual costs based on an initial investment amount of over 1 year assuming a net zero growth rate

Cost Category % of Investment lump sum costs
Our annual fee

Our annual fee

Includes our platform fee at 0.30% per annum (excluding Charles Stanley Multi Asset Funds and anycash held). The min fee is £60, the max is £600 per annum, plus SIPP administration fee (if applicable, only charged if < £30,000 held) – see here
0.30%
Dealing charges

Dealing charges

Any one-off commission charges associated with investing. Note that government taxes and levies are not included. This does not include any commission credits you may have available
N/A
Product provider costs

Product provider costs

Product provider costs shown are inclusive of the fund ongoing charges figure (OCF), transaction costs and incidental costs
N/A N/A
Total (£)

Total (£)

Costs per annum displayed in monetary value
Total (%)

Total (%)

Costs per annum displayed as a percentage of investment value

Cumulative effect of charges on your investment's return

This illustration assumes that costs occur evenly throughout the year, charges are paid out of the investment evenly throughout the year, and that an annual growth rate of applies evenly throughout the year, before any charges including product charges

lump sum invested with an assumed growth rate of 1 year years
What you might get back at  with no charges applied

What you might get back at  with no charges applied

These are the illustrative values of a  investment after growth and no costs applied at the end of the defined period
Annual charges

Annual charges

These are the annual costs based on an initial investment amount of assuming a net zero growth rate
Effect of charges on return (%)

Effect of charges on return (%)

These are the overall costs in percentage terms, based on an initial investment amount of assuming a growth rate
Effect of charges on return (£)

Effect of charges on return (£)

These are the overall costs in monetary value, based on an initial investment amount of assuming a growth rate
What you might get back at with charges applied

What you might get back at with charges applied

These are the illustrative values of a investment after growth and costs at the end of the defined period

This illustration is not a forecast of future investment performance but merely a means to demonstrate the potential impact of costs and charges for an assumed return of . Whilst we make reasonable endeavours to ensure the accuracy of third party charges information, this is intended for illustrative purposes only and should not be relied upon. We do not warrant or represent that this information is accurate, complete or up to date, therefore we accept no responsibility or liability for its use

Charts

  • Chart Options

    Select Timeframe Add a sector as a comparator Add an index as a comparator Add a share as a comparator

      Add a moving average as a comparator Add a lower indicator as a comparator Chart Style Current Comparators

      Company

      Business Summary

      RELX PLC is a United Kingdom-based global provider of information-based analytics and decision tools for professional and business customers. The Company operates in four market segments: Risk; Scientific, Technical & Medical; Legal, and Exhibitions. The Risk segment provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals progress science, advance healthcare and improve performance. The Legal segment provides legal, regulatory and business information and analytics. The Exhibitions segment combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.

      Financial Summary

      BRIEF: For the fiscal year ended 31 December 2024, Relx PLC revenues increased 3% to £9.43B. Net income increased 9% to £1.93B. Revenues reflect Exhibitions segment increase of 11% to £1.24B, Risk & Business information segment increase of 4% to £3.25B, Legal segment increase of 3% to £1.9B, Rest of the World segment increase from £719M to £1.91B, Europe segment increase of 43% to £2.03B, North America segment increase of 3% to £5.5B.

      Financials


      Income Statement - All values are in GBP (M).

      Year Ending

      31/12/2024

      31/12/2023

      31/12/2022

      31/12/2021

      31/12/2020

      31/12/2019

      Total Revenue 9,434.00 9,161.00 8,553.00 7,244.00 7,110.00 7,874.00
      Gross profit 6,134.00 5,945.00 5,508.00 4,682.00 4,623.00 5,119.00
      Operating Profit/Loss 2,855.00 2,610.00 2,314.00 1,939.00 1,655.00 2,152.00
      Profit Before Tax 2,557.00 2,295.00 2,113.00 1,797.00 1,483.00 1,847.00
      Profit After Tax 1,944.00 1,788.00 1,632.00 1,471.00 1,222.00 1,515.00
      Equity Holders of Parent Company 1,934.00 1,781.00 1,634.00 1,471.00 1,224.00 1,505.00
      Minority Interest 13.00 -28.00 -20.00 -8.00 18.00 20.00


      Balance Sheet - All values are in GBP (M).

      Year Ending

      31/12/2024

      31/12/2023

      31/12/2022

      31/12/2021

      31/12/2020

      31/12/2019

      Total Non-Current Assets 12,137.00 12,043.00 12,760.00 11,501.00 11,871.00 11,344.00
      Total Current Assets 2,996.00 2,874.00 3,069.00 2,357.00 2,274.00 2,445.00
      Total Assets 15,133.00 14,917.00 15,829.00 13,858.00 14,145.00 13,789.00
      Total Liabilities 11,629.00 11,478.00 12,075.00 10,634.00 12,044.00 11,599.00
      Total Net Assets 3,504.00 3,439.00 3,754.00 3,224.00 2,101.00 2,190.00
      Shareholders Funds 3,481.00 3,460.00 3,776.00 3,232.00 2,099.00 2,166.00
      Minority Interests 13.00 -28.00 -20.00 -8.00 18.00 20.00
      Total Equity 3,504.00 3,439.00 3,754.00 3,224.00 2,101.00 2,190.00

      Outlook

      Broker View
      Data shown is based on the past 75 days of broker views.

      ActionBrokers

      Strong Buy4

      Buy8

      Neutral4

      Sell0

      Strong Sell0

      Brokers 4 8 4 0 0
      Consensus

      ConsensusBuy

      Not advice based on your circumstances. Does not constitute a recommendation to buy or sell this or any other security. Selected data supplied by Digital Look® Read more.

      © 2022 Refinitiv, an LSEG business. All rights reserved.

      Forecasts

      Year 2025 2026 2027
      Revenue £9,972.94mn £10,694.30mn £11,313.60mn
      Pre-tax-Profit £3,390.35mn £3,669.81mn £3,913.35mn
      EPS £1.31p £1.45p £1.58p
      EPS Growth 9.18% 10.75% 8.78%
      P/E 30.47 27.51 25.28
      PEG Ratio 3.32 2.56 2.88
      Dividend 67.34p 73.30p 79.43p
      Yield 0.00% 0.00% 0.00%

      Upgrades & Downgrades (Latest)

      DateBrokerRecommendationPriceOld TargetNew TargetChange
      18th Feb 2025JP Morgan CazenoveReiteration4029p0p4770pOverweight
      7th Jan 2025JP Morgan CazenoveReiteration3699p0p4550pOverweight
      5th Dec 2024JP Morgan CazenoveReiteration3784p0p4550pOverweight
      4th Jul 2024CitigroupReiteration3583p0p0pNeutral
      16th Feb 2024JP Morgan CazenoveReiteration3402p3770p4100pOverweight
      5th Jan 2024Berenberg BankReiteration3100p3270p3300pBuy
      10th Nov 2023Berenberg BankReiteration2955p0p3270pBuy
      3rd Oct 2023BarclaysReiteration2760p2770p2860pEqual-weight
      27th Sep 2023Berenberg BankNew Coverage2741p0p3270pBuy
      13th Sep 2023JP Morgan CazenoveReiteration2744p3100p3170pOverweight

      Time & Sales

      Sorry, sales information on this investment is not available at this time.

      Investment involves risk. You may get back less than invested.